Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
Clinical trial NCT05838729 · RECRUITING
Trial details
- NCT number
- NCT05838729
- Sponsor
- Coordination Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-03
- Primary completion
- 2026-09-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.